April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
A new treatment for corneal thinning using a biocompatible cross linker and femtosecond laser
Author Affiliations & Notes
  • Takeshi Soma
    Dept of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Michiya Matsusaki
    Department of Applied Chemistry, Osaka University Graduate School of Engineering, Suita, Japan
  • Masahiro Matsumoto
    Department of Applied Chemistry, Osaka University Graduate School of Engineering, Suita, Japan
  • Hiroharu Ajiro
    Department of Applied Chemistry, Osaka University Graduate School of Engineering, Suita, Japan
  • Ryuhei Hayashi
    Dept of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Motokazu Tsujikawa
    Dept of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Yoshinori Oie
    Dept of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Mitsuru Akashi
    Department of Applied Chemistry, Osaka University Graduate School of Engineering, Suita, Japan
  • Kohji Nishida
    Dept of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan
  • Footnotes
    Commercial Relationships Takeshi Soma, None; Michiya Matsusaki, None; Masahiro Matsumoto, None; Hiroharu Ajiro, None; Ryuhei Hayashi, None; Motokazu Tsujikawa, None; Yoshinori Oie, None; Mitsuru Akashi, None; Kohji Nishida, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5168. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takeshi Soma, Michiya Matsusaki, Masahiro Matsumoto, Hiroharu Ajiro, Ryuhei Hayashi, Motokazu Tsujikawa, Yoshinori Oie, Mitsuru Akashi, Kohji Nishida; A new treatment for corneal thinning using a biocompatible cross linker and femtosecond laser. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5168.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Corneal stromal thinning such as keratoconus can be treated by allogeneic corneal transplantation. However, there remain many problems such as immune rejection and the shortage of donor corneas. We investigated a new treatment for corneal thinning using a biocompatible cross linker and femtosecond laser (FSL) in rabbit eye.

Methods: A circular horizontal lamellar dissection (8.0-mm diameter) was created at one-half the thickness of the stroma using FSL (N=14). Biocompatible cross linker and type 1 atelocollagen were injected into the stromal interlayer (N=9). In control eyes, nothing was injected (N=5). Reconstructed corneas were assessed with slitlamp photograph and optical coherence tomography (OCT), and corneal thickness was measured with pachymeter before and 1 and 4 week(s) after injection. Histological examination was performed in enucleated eyes 4 weeks postoperatively.

Results: The average corneal thickness before and 1 and 4 week(s) after injection were 325, 531, and 400-μm in the treated eyes, and 315, 343, 329-μm in the control eyes. The treated corneas were significantly thicker than those in the control eyes on 1 and 4 week(s) postoperatively (p=0.00003, 0.00002; t-test with Bonferroni correction). Slit lamp photograph showed slight opacity was found in the cornea of injected eyes. Artificial corneal stromal layer was observed in the treated eyes with OCT and histological examination. Immunohistochemistry revealed that there was no inflammation in the treated corneas.

Conclusions: A new method with a biocompatible cross linker and FSL might be effective for thickening of corneal stroma in rabbit eye.

Keywords: 484 cornea: stroma and keratocytes • 687 regeneration • 607 nanotechnology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×